| |
AsCNP |
KCNP |
| Emerald A |
Emerald B |
Diamond |
Swan |
Flamingo |
| 09:00 ~ 09:15 |
Opening Ceremony |
|
|
|
| 09:15 ~ 10:00 |
Plenary Lecture 1
A Role of AKT-GSK3 Signaling Pathway in the Action of Atypical Antipsychotic Drugs |
| 10:00 ~ 10:20 |
Coffee Break |
| 10:20 ~ 12:00 |
Symposium 1
Optimal Pharmacological Treatment for Patients with First Episode Psychosis (FEP) |
Symposium 2
Recent Advances in Pharmacotherapy for Mood Disorders |
Symposium 3
Breaking Researches on Neuropsychopharmacology : From Basic Neuroscience Research to Clinical Study
|
Symposium 4
New Targets for Medical Treatment of Substance Use Disorders |
K-Symposium 1
Some Big Questions for Bipolar Disorder |
| 12:10 ~ 13:10 |
Luncheon Seminar 1 |
Luncheon Seminar 2 |
Luncheon Seminar 3 |
|
|
| 13:10 ~ 13:50 |
Poster Presentations (
Exhibition Hall,
Convention Center 1F) |
| 13:50 ~ 15:30 |
Symposium 5
Translational Researches on Bipolar Disorders: From Bench to Clinic |
Symposium 6
Study of Bipolar Disorder among the South-East Asia Countries |
Symposium 7
A New Paradigm of Genetic Studies in Psychopharmacology |
New Research 1
(Oral Presentation 1) |
K-Symposium 2
Sleep and Wake: From Basic Science to Clinical Practice |
| 15:30 ~ 16:20 |
Special Lecture 1
Glutamatergic Treatment Strategies for Schizophrenia and Depression: A Translational Neuroscience Perspective |
Special Lecture 2
Social Cognition in Schizophrenia |
Meet the Expert 1
New Approaches to Targeting Muscarinic Receptors to Treat Psychiatric Disorders |
|
K-Special Lecture 1
Perspectives on Psychiatric Genetics: What We Know and Why We Don’t Know What We Don’t Know |
| 16:20 ~ 16:40 |
Coffee Break |
| 16:40 ~ 18:20 |
Thematic Lectures
Advances in Asian
Neuropsycho-pharmacology |
Symposium 8
Social-emotional Memory Processing in Psychiatric Disorders: A New Aspect of Psychopharmacology |
Symposium 9
Depression – From Aetiology to Pathology and Treatment Effects |
Symposium 10
Neurogenesis in Ddepression and Addiction |
K-Symposium 3
Evidence-based Treatment for ADHD: "Real-World" Practice Implications |
| 18:20 ~ 18:30 |
|
|
|
| 18:30 ~ 21:00 |
Evening Lecture & Welcome Reception
(Grand Ballroom) |
| |
AsCNP |
KCNP |
| Emerald A |
Emerald B |
Diamond |
Swan |
Flamingo |
| 09:00 ~ 09:45 |
Plenary Lecture 2
Progress in Schizophrenia Research and Its Relation to Future Drug Developments and Treatment Strategies |
|
|
|
| 09:45 ~10:05 |
Coffee Break |
| 10:05 ~ 11:45 |
Symposium 11
(AsCNP-CINP Joint Symposium)
Recent Advances in Neuropsycho-pharmacology
|
Symposium 12
Maximization of Clinical Benefit of Clozapine in Asian Countries |
Symposium 13
Omega-3 Fatty Acids in Depression and Anxiety: From Bench to Bedside |
Symposium 14
The
Neuropsycho-pharmacological Treatment Approach in ADHD: from Neurobiological to Functional Imaging Perspective |
K-Symposium 4 Discrepancies of Pharmacotherapy Between Textbooks and Real World Clinical Practice, Part III |
| 11:45 ~ 12:30 |
Special Lecture 3
Back to the Future: Seeking Novel Drugs from Traditional Knowledge |
Special Lecture 4
Neuroimaging of Social Brain and Emotional Brain: Implications for Mood Disorder and Eating Disorder |
Meet the Expert 2
OCD – Focus on Where We Draw the Line on Issues such as Delusions and Obsessions, Behavioral Addiction and Treatment Resistant OCD |
|
K-Special Lecture 2
Dementia is a Mental Illness! |
| 12:40 ~ 13:40 |
Luncheon Seminar 4 |
Luncheon Seminar 5 |
Luncheon Lecture |
|
| 13:40 ~ 14:30 |
Poster Presentations (Exhibition Hall,
Convention Center 1F) |
| 14:30 ~16:10 |
Symposium 15
Recent Advances in Pharmacotherapy for Anxiety Disorders |
Symposium 16
Psychopathology and Electrophysiological Abnormality of Schizophrenia Patients |
Symposium 17
Genetics and Neuroimaging of Autism Spectrum Disorders (ASD): Targeting to the Pharmacological Approach |
New Research 2
(Oral Presentation 2) |
K-Symposium 5
Good Psychopharma-cology Needs Good Nosology |
| 16:10 ~ 16:30 |
Closing Ceremony |
|
|
|
|
